HIV Treatment: ALERTS! articles

Recent articles from HIV Treatment: ALERTS!

The 14th Conference on Retroviruses and Opportunistic Infections (CROI): Los Angeles, February 25th-28th.(HIGHLIGHTS)
June 1, 2007... The 14th Conference on Retroviruses and Opportunistic Infections (CROI), held in Los Angeles from February 25th to the 28th, is one of the biggest HIV science conferences held each year. As in past years, the world's leading researchers presented their findings from work they have been doing...

New drug profile: Maraviroc: it's different, it's strong, and it's almost here.(Drug overview)
June 1, 2007... What is it? Maraviroc (or Celsentri) is an HIV medication, the first of its kind. Maraviroc doesn't block HIV directly; instead, maraviroc binds to a human protein known as CCR5. This is one of the proteins HIV uses to enter human T cells. By binding to CCR5, maraviroc keeps HIV from...

HIV super strain revisited.(IN THE NEWS)
June 1, 2007... In the April 2005 edition of The Center for AIDS Information & Advocacy HIV Treatment ALERTS! we reported the strange case of a 40-something year old, gay man in New York City (referred to as NYC) who appeared to be newly infected with a form or "strain" of HIV that was resistant to the 3...

Green tea: fact or fiction.(treatment news)
June 1, 2007... Scientists have discovered that a substance in green tea prevents HIV from attaching to our immune system cells by getting there first. According to researchers from Baylor College of Medicine in Houston and the University of Sheffield in the England, in a report that appears in the Journal...

Fuzeon update.(Brief article)
June 1, 2007... In January, new precautions were added to the labeling for the injectable HIV fusion inhibitor Fuzeon. The new information focuses on side effects reported when the Biojector 2000 needle-free device is used to inject Fuzeon. In addition, the correct injection sites are spelled out. ...